Revolution Medicines (RVMD) Profit After Tax (2019 - 2026)
Revolution Medicines (RVMD) posted Profit After Tax of -$644.4 million for Q2 2026, down 41.99% on a QoQ basis from -$453.8 million in Q1 2026, and down 160.05% year-over-year from $1.1 billion in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Profit After Tax (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Profit After Tax for 8 years, with the latest figure at -$644.4 million in Q2 2026.
- On a quarterly basis, Profit After Tax fell 160.05% year-over-year to -$644.4 million in Q2 2026; TTM through Jun 2026 was -$1.8 billion, a 117.75% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 88.52% from the prior year.
- Profit After Tax was -$644.4 million for Q2 2026 at Revolution Medicines, down from -$453.8 million in the prior quarter.
- The five-year high for Profit After Tax was -$57.6 million in Q1 2022, with the low at -$644.4 million in Q2 2026.
- Average Profit After Tax over 5 years is -$195.3 million, with a median of -$144.8 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax declined 8.92% in 2022, then tumbled 178.94% in 2023.
- Over 5 years, Profit After Tax stood at -$57.9 million in 2022, then sank by 178.94% to -$161.5 million in 2023, then dropped by 20.45% to -$194.6 million in 2024, then plunged by 87.54% to -$364.9 million in 2025, then tumbled by 76.59% to -$644.4 million in 2026.
- The last three Profit After Tax figures came in at -$644.4 million (Q2 2026), -$453.8 million (Q1 2026), and -$364.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -248.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | -644.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -644.37 Mn |
| Mar 31, 2026 | -453.82 Mn |
| Dec 31, 2025 | -364.89 Mn |
| Sep 30, 2025 | -305.21 Mn |
| Jun 30, 2025 | -247.79 Mn |
| Mar 31, 2025 | -213.42 Mn |
| Dec 31, 2024 | -194.57 Mn |
| Sep 30, 2024 | -156.29 Mn |
| Jun 30, 2024 | -133.23 Mn |
| Mar 31, 2024 | -116.00 Mn |
| Dec 31, 2023 | -161.54 Mn |
| Sep 30, 2023 | -108.43 Mn |
| Jun 30, 2023 | -98.30 Mn |
| Mar 31, 2023 | -68.10 Mn |
| Dec 31, 2022 | -57.91 Mn |
| Sep 30, 2022 | -73.33 Mn |
| Jun 30, 2022 | -61.22 Mn |
| Mar 31, 2022 | -57.65 Mn |
| Dec 31, 2021 | -53.17 Mn |
| Sep 30, 2021 | -52.94 Mn |
API Access
Revolution Medicines Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();